Friday, June 30, 2017

Liquid Biopsies: A Non-invasive Look at Treatment Response

A new study, to be presented at the ESMO 19th World Congress on Gastrointestinal Cancer, shows that so-called “liquid biopsies”, blood tests that detect circulating tumour DNA, may not only sound an early alert that a treatment’s effect is diminishing, but may also help explain why -- sometimes offering clues about what to do next. Why a cancer treatment is losing its effectiveness is a question that preoccupies every patient and their doctor. But checking in on a drug’s tumor-fighting progress is not easy -- usually involving invasive biopsies and expensive scans.

Link to full European Society for Medical Oncology release on presentation by MGH investigator Aparna Parikh.

Browse the Entire Newsroom Archive

Back to Top